PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With Hyperammonemia

NCT06135675 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperammonemia

Interventions

DRUG: TNP-2092 capsules
DRUG: Placebo

Sponsor

TenNor Therapeutics (Suzhou) Limited

Collaborators

[object Object]